Jinpeng Li

4PUBLICATIONS
0CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tissue engineeringMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 10, 2025
Letter to the Editor: Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment.

Qingran Liu, Jinpeng Li, Hua Chen

|Dec 23, 2024
Letter to the Editor: Intrahepatic IgA complex induces polarization of cancer-associated fibroblasts to matrix phenotypes in the tumor microenvironment of hepatocellular carcinoma.

Shuangshuang Ma, Jiao Chen, Jinpeng Li

|Dec 23, 2021
Identification of triple gene fusion ALK-LRRN2, LTBP1-ALK, and HIP1-ALK in advanced lung adenocarcinoma and response to alectinib: A case report.

Shangkun Ning, Congcong Shi, Huifang Zhang

|Dec 06, 2021
Determination of risk factors for fever after transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma.

Jinpeng Li, Congcong Shi, Jutian Shi

Pageof 1

Frequent Collaborators